FESK.COMYour global study desk
Email us
Home › Scholar › Vu Van Vu
COMPILEDopen profilenot managed by this scholar
V

Vu Van Vu

Researcher Profile 5/10
This is my profile

Information

Featured publications

Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis514 citations
JNCI Journal of the National Cancer Institute · 2013 · DOI
Use of Azolla as a test organism in a growth chamber of simple design14 citations
Plant and Soil · 1987 · DOI
Synthesis and Biological Evaluation of New (−)-Gossypol-Derived Schiff Bases and Hydrazones8 citations
Journal of Chemistry · 2017 · DOI
Novel (-)-gossypol derived hydrazones: Synthesis and biological evaluation3 citations
AIP conference proceedings · 2017 · DOI
Synthesis of New Zerumbone Hydrazones and Their In-vitro Anticancer Activity3 citations
Current Bioactive Compounds · 2020 · DOI
A New Synthetic Route for Preparation of Enantiomers of Gossypol and Apogossypol from Racemic Gossypol
Asian Journal of Chemistry · 2018 · DOI
Proceeding of the Annual ACM-SIAM Symposium on Discrete Algorithms: Preface
Rare & Special e-Zone (The Hong Kong University of Science and Technology) · 2005

About the field of Medicine and Pharmacy

Common research topics in this field:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Institutions with the most researchers in this field:

These figures count profiles currently in this directory, not nationwide statistics.

The publication list above is compiled from the open academic database OpenAlex (CC0 licence). Compare with the source record on OpenAlex ↗

Suggest / Claim this profile

  
Profile aggregated from public sources. We respect scholars' rights to edit and remove information — all requests are processed promptly.
Vu Van VuHanoi University of Science and Technology
Claim
Original profile stored athocthuat.vn— two pages display the same database, verification syncs everywhere.